Financhill
Sell
48

ATNM Quote, Financials, Valuation and Earnings

Last price:
$1.19
Seasonality move :
5.17%
Day range:
$1.23 - $1.30
52-week range:
$1.03 - $10.24
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
1.06x
Volume:
187.7K
Avg. volume:
159.3K
1-year change:
-80.74%
Market cap:
$40.6M
Revenue:
$81K
EPS (TTM):
-$1.39

Earnings Data

Next earnings date for ATNM
Apr 25
2025
Most recent earnings per share
-$0.37
Missed by $0.00
(Nov 14/2024)
Consensus Estimate
-$0.37
(Nov 14/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

ATNM Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
04/25/2025 Q1 -- -- -- -$0.38 --
12/31/2024 Q4 -- -- -- -$0.39 --
11/14/2024 Q3 -- -- -$0.37 -$0.37 -$0.00
08/05/2024 Q2 -- -- -$0.38 -$0.40 $0.02
04/26/2024 Q1 -- -- -$0.31 -$0.52 $0.21
12/31/2023 Q4 -- $81K -$0.33 -$0.54 $0.21
11/02/2023 Q3 $460K -- -$0.49 -$0.57 $0.08
08/14/2023 Q2 -- -- -$0.58 -$0.49 -$0.09
05/15/2023 Q1 -- -- -$0.43 -$0.43 $0.00
12/31/2022 Q4 $1M -- -$0.43 -$0.34 -$0.09
11/14/2022 Q3 -- $45K -$0.38 -- --
08/12/2022 Q2 -- $45K -$0.33 -- --
05/13/2022 Q1 -- $940K -$0.23 -- --
02/24/2022 Q4 -- $23K -$0.36 -- --
11/12/2021 Q3 -- $233K -$0.30 -- --
07/30/2021 Q2 -- $266K -$0.25 -- --
05/14/2021 Q1 -- $622K -$0.29 -- --
12/31/2020 Q4 -- -- -$0.37 -- --
10/23/2020 Q3 -- -- -$0.36 -- --
06/30/2020 Q2 -- -- -$0.41 -- --
05/08/2020 Q1 -- -- -$0.98 -- --
03/19/2020 Q4 -- -- -$0.80 -- --
10/28/2019 Q3 -- -- -$1.21 -- --
08/09/2019 Q2 -- -- -$1.00 -- --
03/31/2019 Q1 -- -- -$1.50 -- --
03/19/2019 Q4 -- -- -$1.50 -- --
11/09/2018 Q3 -- -- -$1.80 -- --
08/09/2018 Q2 -- -- -$1.20 -- --
03/31/2018 Q1 -- -- -$2.10 -- --
12/31/2017 Q4 -- -- -$1.80 -- --
11/03/2017 Q3 -- -- -$2.70 -- --
08/04/2017 Q2 -- -- -$3.60 -- --
03/31/2017 Q1 -- -- -$4.20 -- --
03/17/2017 Q4 -- -- -$3.60 -- --
10/28/2016 Q3 -- -- -$4.20 -- --
07/29/2016 Q2 -- -- -$4.20 -- --
05/13/2016 Q1 -- -- -$3.00 -- --
04/04/2016 Q4 -- -- -$4.80 -- --
11/27/2015 Q3 -- -- -$3.00 -- --
08/14/2015 Q2 -- -- -$6.00 -- --
03/31/2015 Q1 -- -- -$2.70 -- --

Actinium Pharmaceuticals Earnings Questions

  • How Much did Actinium Pharmaceuticals Generate in Revenue Last Quarter?

    Actinium Pharmaceuticals reported -- worth of top line sales in its most recent quarter.

  • Did Actinium Pharmaceuticals Beat Earnings Last Quarter?

    Actinium Pharmaceuticals announced earnings per share of -$0.37 which represents a miss of analyst forecast a -$0.37 per share.

  • Is Actinium Pharmaceuticals Profitable?

    Actinium Pharmaceuticals reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Actinium Pharmaceuticals EPS Next Year?

    Actinium Pharmaceuticals's earnings are forecast to decrease from -$1.83 per share to -$1.43 per share next year representing a decrease of -61.89%.

  • When is Actinium Pharmaceuticals's Earnings Date?

    Actinium Pharmaceuticals's next earnings date is April 25, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is CyberArk The Next Big Cybersecurity Stock?
Is CyberArk The Next Big Cybersecurity Stock?

CyberArk Software (NASDAQ: CYBR) recently reported phenomenal quarter numbers, passing…

Is the Market Going to Go Lower?
Is the Market Going to Go Lower?

The last month has been extremely difficult for the stock…

2 Dividend Stocks to Buy in a Recession
2 Dividend Stocks to Buy in a Recession

While many economists and investors initially expected 2025 to be…

Stock Ideas

Buy
53
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Buy
54
Is NVDA Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 41x

Buy
51
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Alerts

Buy
52
RGC alert for Mar 18

Regencell Bioscience Holdings [RGC] is up 73.51% over the past day.

Buy
63
EXOD alert for Mar 18

Exodus Movement [EXOD] is down 3.96% over the past day.

Sell
45
MNPR alert for Mar 18

Monopar Therapeutics [MNPR] is up 0.93% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock